⸺ Celvora
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Size
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About Retatrutide
Retatrutide is a synthetic peptide investigated for its action across three metabolic receptor pathways simultaneously. Researchers use it in preclinical models to study integrated effects on appetite signalling, energy expenditure, lipid handling and glycaemic control.
⸺ Mechanism of Action
How it works
Retatrutide activates three hormone receptors at once — GLP-1, GIP and glucagon — which together regulate blood sugar, energy use and digestion.
⸺ Research
Areas of study
Metabolic effects in rodent models
Animal studies indicate Retatrutide engages multiple hormonal pathways involved in energy regulation.
Glucose homeostasis in mice
Mouse research suggests Retatrutide enhances insulin sensitivity and stabilises blood glucose levels.
Liver function in rats
In rat models, Retatrutide has been associated with improved liver enzyme markers.
⸺ Details
Specification
- CAS
- 2381089-83-2
- Intended use
- For research purposes only.
- Storage
- Store lyophilised vials cool, dry and out of direct sunlight. Refrigerate once reconstituted.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Use sterile technique.
You might also research
View all →
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.
Cagrilintide
Long-acting amylin analogue researched for appetite regulation and weight management, often paired with GLP-1 agonists.